Charles N. York II

2015

In 2015, Charles N. York II earned a total compensation of $394.7K as Chief Financial Officer and Vice President at Aeglea BioTherapeutics.

Compensation breakdown

Bonus$61,200
Salary$233,165
Stock Awards$95,031
Other$5,299
Total$394,695

York received $233.2K in salary, accounting for 59% of the total pay in 2015.

York also received $61.2K in bonus, $95K in stock awards and $5.3K in other compensation.

Rankings

In 2015, Charles N. York II's compensation ranked 11,602nd out of 13,638 executives tracked by ExecPay. In other words, York earned more than 14.9% of executives.

ClassificationRankingPercentile
All
11,602
out of 13,638
15th
Division
Manufacturing
4,449
out of 5,187
14th
Major group
Chemicals And Allied Products
1,643
out of 1,857
12th
Industry group
Drugs
1,359
out of 1,531
11th
Industry
Pharmaceutical Preparations
1,050
out of 1,179
11th
Source: SEC filing on April 21, 2017.

York's colleagues

We found two more compensation records of executives who worked with Charles N. York II at Aeglea BioTherapeutics in 2015.

2015

David Lowe

Aeglea BioTherapeutics

Chief Executive Officer

2015

Scott Rowlinson

Aeglea BioTherapeutics

Vice President, Research

News

You may also like